p16 loss rescues functional decline of Brca1-deficient mammary stem cells

被引:7
|
作者
Scott, Alexandria [1 ,2 ]
Bai, Feng [1 ,4 ]
Chan, Ho Lam [1 ]
Liu, Shiqin [1 ]
Slingerland, Joyce M. [3 ]
Robbins, David J. [1 ,4 ]
Capobianco, Anthony J. [1 ,4 ]
Pei, Xin-Hai [1 ,2 ,4 ]
机构
[1] Univ Miami, Miller Sch Med, Mol Oncol Program, Dept Surg, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Canc Ctr, Miami, FL 33136 USA
[4] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Miami, FL 33136 USA
关键词
p16(INK4a); Brca1; senescence; stem cell function; DNA-DAMAGE; AGE; EXPRESSION; P16(INK4A); REPAIR; GENE;
D O I
10.1080/15384101.2017.1295185
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recent evidence indicates that the accumulation of endogenous DNA damage can induce senescence and limit the function of adult stem cells. It remains elusive whether deficiency in DNA damage repair is associated with the functional alteration of mammary stem cells. In this article, we reported that senescence was induced in mammary epithelial cells during aging along with increased expression of p16Ink4a (p16), an inhibitor of CDK4 and CKD6. Loss of p16 abrogated the age-induced senescence in mammary epithelial cells and significantly increased mammary stem cell function. We showed that loss of Brca1, a tumor suppressor that functions in DNA damage repair, in the mammary epithelium induced senescence with induction of p16 and a decline of stem cell function, which was rescued by p16 loss. These data not only answer the question as to whether deficiency in DNA damage repair is associated with the functional decline of mammary stem cells, but also identify the role of p16 in suppressing Brca1-deficient mammary stem cell function.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 50 条
  • [1] p16INK4a suppresses BRCA1-deficient mammary tumorigenesis
    Scott, Alexandria
    Bai, Feng
    Chan, Ho Lam
    Liu, Shiqin
    Ma, Jinshan
    Slingerland, Joyce M.
    Robbins, David J.
    Capobianco, Anthony J.
    Pei, Xin-Hai
    ONCOTARGET, 2016, 7 (51): : 84496 - 84507
  • [2] Mammary tumor formation in p53- and BRCA1-deficient mice
    Cressman, VL
    Backlund, DC
    Hicks, EM
    Gowen, LC
    Godfrey, V
    Koller, BH
    CELL GROWTH & DIFFERENTIATION, 1999, 10 (01): : 1 - 10
  • [3] Cell cycle checkpoints in BRCA1-deficient embryonic stem cells
    Snouwaert, JN
    Pace, AJ
    Gowen, LC
    Xiao, A
    Nichols, MA
    Xiong, Y
    Koller, BH
    FASEB JOURNAL, 1999, 13 (07): : A1538 - A1538
  • [4] FUNCTIONAL HETEROGENEITY OF ACQUIRED PARP INHIBITOR RESISTANCE IN BRCA1-DEFICIENT CELLS
    Farkkila, Anniina
    Rodriquez, Alfredo
    Olkkonen, Jaana
    Sambel, Larissa
    Dominiquez, Julieta
    Joshi, Niraj
    Clairmont, Connor
    Zhou, Jia
    Lim, Kah-Suan
    Hautaniemi, Sampsa
    D'Andrea, Alan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 204 - 204
  • [5] PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
    Feng Bai
    Shiqin Liu
    Xiong Liu
    Daniel P. Hollern
    Alexandria Scott
    Chuying Wang
    Lihan Zhang
    Cheng Fan
    Li Fu
    Charles M. Perou
    Wei-Guo Zhu
    Xin-Hai Pei
    Breast Cancer Research, 23
  • [6] PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
    Bai, Feng
    Liu, Shiqin
    Liu, Xiong
    Hollern, Daniel P.
    Scott, Alexandria
    Wang, Chuying
    Zhang, Lihan
    Fan, Cheng
    Fu, Li
    Perou, Charles M.
    Zhu, Wei-Guo
    Pei, Xin-Hai
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [7] Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS
    Sgagias, MK
    Wagner, KU
    Hamik, B
    Stoeger, S
    Spieker, R
    Huber, LJ
    Chodosh, LA
    Cowan, KH
    CELL CYCLE, 2004, 3 (11) : 1451 - 1456
  • [8] Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
    Rottenberg, Sven
    Vollebergh, Marieke A.
    de Hoon, Bas
    de Ronde, Jorma
    Schouten, Philip C.
    Kersbergen, Ariena
    Zander, Serge A. L.
    Pajic, Marina
    Jaspers, Janneke E.
    Jonkers, Martijn
    Loden, Martin
    Sol, Wendy
    van der Burg, Eline
    Wesseling, Jelle
    Gillet, Jean-Pierre
    Gottesman, Michael M.
    Gribnau, Joost
    Wessels, Lodewyk
    Linn, Sabine C.
    Jonkers, Jos
    Borst, Piet
    CANCER RESEARCH, 2012, 72 (09) : 2350 - 2361
  • [9] Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
    Tsang, Siu Man
    Kim, Hyojin
    Oliemuller, Erik
    Newman, Richard
    Boateng, Naa-Anyima
    Guppy, Naomi
    Howard, Beatrice A.
    DISEASE MODELS & MECHANISMS, 2021, 14 (05)
  • [10] Characterization of a novel p53; BRCA1-deficient claudin-low mammary tumor cell line
    Dance-Barnes, Stephanie T.
    Evans, Ebone
    Steward, Shanderys
    He, Xiaping
    Usary, Jerry
    Perou, Charles
    CANCER RESEARCH, 2016, 76